Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients
Authors
Keywords
Lung cancer, DNA methylation, DCLK1, Free-circulating DNA
Journal
Clinical & Translational Oncology
Volume 18, Issue 4, Pages 398-404
Publisher
Springer Nature
Online
2015-08-26
DOI
10.1007/s12094-015-1382-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The recently suggested intestinal cancer stem cell markerDCLK1is an epigenetic biomarker for colorectal cancer
- (2014) Hege Marie Vedeld et al. Epigenetics
- Septin 9 promoter region methylation in free circulating DNA—potential role in noninvasive diagnosis of lung cancer: preliminary report
- (2014) Tomasz Powrózek et al. MEDICAL ONCOLOGY
- Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island
- (2013) Reinhold Wasserkort et al. BMC CANCER
- Computed Tomography Screening for Lung Cancer
- (2013) Phillip M. Boiselle JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
- (2013) Juan Sandoval et al. JOURNAL OF CLINICAL ONCOLOGY
- Association between MGMT Promoter Methylation and Non-Small Cell Lung Cancer: A Meta-Analysis
- (2013) Changmei Gu et al. PLoS One
- Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
- (2012) Kim Andresen et al. Epigenetics
- Dclk1 distinguishes between tumor and normal stem cells in the intestine
- (2012) Yuki Nakanishi et al. NATURE GENETICS
- EPD and EPDnew, high-quality promoter resources in the next-generation sequencing era
- (2012) René Dreos et al. NUCLEIC ACIDS RESEARCH
- Methylation Markers of Early-Stage Non-Small Cell Lung Cancer
- (2012) Kaie Lokk et al. PLoS One
- Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
- (2011) Jorja D Warren et al. BMC Medicine
- EFEMP1 as a Novel DNA Methylation Marker for Prostate Cancer: Array-Based DNA Methylation and Expression Profiling
- (2011) Y.-J. Kim et al. CLINICAL CANCER RESEARCH
- Lung Cancer: Epidemiology, Etiology, and Prevention
- (2011) Charles S. Dela Cruz et al. CLINICS IN CHEST MEDICINE
- TFPI-2 methylation predicts poor prognosis in non-small cell lung cancer
- (2011) Duoguang Wu et al. LUNG CANCER
- Screening for lung cancer: are we there yet?
- (2010) Maurizio V Infante et al. CURRENT OPINION IN PULMONARY MEDICINE
- Multicenter Clinical Validation of PITX2 Methylation as a Prostate Specific Antigen Recurrence Predictor in Patients With Post-Radical Prostatectomy Prostate Cancer
- (2010) Lionel L. Bañez et al. JOURNAL OF UROLOGY
- Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).
- (2009) Wieslawa Niklinska et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now